Jw Life Science Corp (234080) — Cash Flow Reinvestment Rate
Jw Life Science Corp (234080) has a Cash Flow Reinvestment Rate of 0.84x as of December 2025, reinvesting ₩4.27 Billion (capex ₩4.27 Billion ) from operating cash flow of ₩5.08 Billion. Explore Jw Life Science Corp (234080) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Jw Life Science Corp Cash Flow Reinvestment Rate (2015–2025)
Historical reinvestment intensity for Jw Life Science Corp across 11 annual periods. Also explore Jw Life Science Corp total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Jw Life Science Corp (2015–2025)
Year-by-year capital reinvestment analysis for Jw Life Science Corp. For live market cap and broader valuation context, see how much is Jw Life Science Corp worth.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.33x | ₩13.43 Billion | ₩40.54 Billion | ₩13.43 Billion | ▼ -0.1% |
| 2024 | 0.33x | ₩16.82 Billion | ₩50.69 Billion | ₩10.31 Billion | ▼ -50.7% |
| 2023 | 0.67x | ₩25.28 Billion | ₩37.57 Billion | ₩8.27 Billion | ▼ -74.0% |
| 2022 | 2.59x | ₩36.54 Billion | ₩14.13 Billion | ₩8.29 Billion | ▲ +297.4% |
| 2021 | 0.65x | ₩19.63 Billion | ₩30.17 Billion | ₩18.98 Billion | ▼ -14.6% |
| 2020 | 0.76x | ₩35.63 Billion | ₩46.75 Billion | ₩15.93 Billion | ▲ +128.3% |
| 2019 | 0.33x | ₩8.10 Billion | ₩24.28 Billion | ₩8.09 Billion | ▲ +20.0% |
| 2018 | 0.28x | ₩10.05 Billion | ₩36.13 Billion | ₩10.04 Billion | ▼ -30.7% |
| 2017 | 0.40x | ₩8.85 Billion | ₩22.05 Billion | ₩8.77 Billion | ▼ -73.8% |
| 2016 | 1.53x | ₩24.65 Billion | ₩16.08 Billion | ₩13.37 Billion | ▲ +70.2% |
| 2015 | 0.90x | ₩23.32 Billion | ₩25.90 Billion | ₩23.14 Billion | — |